View in EDS

Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET.

Saved in:
Bibliographic Details
Title: Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET.
Authors: Lambidis E; Department of Chemistry, Radiochemistry, University of Helsinki, Helsinki FI-00014, Finland., Chen CC; Department of Molecular and Cellular Biology, University of California, Davis, California 95616, United States., Baikoghli M; Department of Molecular and Cellular Biology, University of California, Davis, California 95616, United States., Imlimthan S; Department of Chemistry, Radiochemistry, University of Helsinki, Helsinki FI-00014, Finland., Khng YC; Department of Chemistry, Radiochemistry, University of Helsinki, Helsinki FI-00014, Finland., Sarparanta M; Department of Chemistry, Radiochemistry, University of Helsinki, Helsinki FI-00014, Finland., Cheng RH; Department of Molecular and Cellular Biology, University of California, Davis, California 95616, United States., Airaksinen AJ; Department of Chemistry, Radiochemistry, University of Helsinki, Helsinki FI-00014, Finland.; Turku PET Centre, Department of Chemistry, University of Turku, Turku FI-20520, Finland.
Source: Molecular pharmaceutics [Mol Pharm] 2022 Aug 01; Vol. 19 (8), pp. 2971-2979. Date of Electronic Publication: 2022 Jul 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1543-8392
DOI:10.1021/acs.molpharmaceut.2c00359